Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

When Immunodeficiency & Autoimmunity Coexist

Susan Bernstein  |  December 18, 2018

Epigenetics may offer clues about loss of tolerance in CVID. In one study, DNA methylation patterns in monozygotic twins were discordant for CVID.

“We do know that as those B cells start to mature, the methylation on those B cells remains hyper compared with normal individuals. There is some inherent defect in methylation status of patients with a common variable,” said Dr. Gershwin.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

First-line treatment for CVID is lifelong immunoglobulin replacement, either subcutaneous or intravenous. The most common complications are immune thrombocytopenia and autoimmune hemolytic anemia. Treatments for CVID patients with autoimmunity include an array of immunosuppressants, including biologics.

IPEX
Another primary immune deficiency that may overlap with autoimmune disease is IPEX, which stands for immune deficiency, polyendocrinopathy, enteropathy, X-linked inheritance.4 IPEX, as in a number of other primary immunodeficiencies, is caused by defects on the X chromosome.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

IPEX is caused by a defective FOXP3 transcription factor gene, which leads to a reduction in T regulatory cells, which then leads to immune dysregulation and loss of tolerance. Children with IPEX will die if they don’t have bone marrow transplants, said Dr. Gershwin.

T regulatory cells express FOXP3, which is critical in the transfer of immune tolerance, especially self-tolerance. Also, a related primary immune-deficiency, IPEX-like disease is found in females who have defective T regulatory cells caused by mutations in the IL2r (CD25) or signal transducer and activator of transcription (STAT) genes.

The effect of individual IPEX mutations on FOXP3 expression and function is variable, said Dr. Gershwin. “Any mutation of the functional area of the molecule has implications downstream. And this is best illustrated by IPEX: 60 unique mutations have been recorded of the FOXP3 gene. The [effect] of these mutations on the individual is like a crapshoot. It’s not always predictable,” he said.

IPEX disease severity and symptoms may vary considerably between even two patients with the same gene mutation, which suggests severity may be modulated by other disease-modifying genes that affect T regulatory cell function, as well as variability in the T cell receptor repertoire, the major histocompatibility complex haplotype or epigenetic and environmental factors.

Patients with IPEX have enteropathy that usually presents as intractable diarrhea. Because of defects in their T regulatory cell function, these patients have no control of complex gut immune components.

“If you don’t have FOXP3, you won’t have normal thymic selection,” said Dr. Gershwin. “Thymic selection, the forbidden clone, is the key to understanding how loss of tolerance takes place at least in some cases.”

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:Uncategorized Tagged with:common variable immune deficiencyimmune deficiency polyendocrinopathy enteropathy X-linked inheritance (IPEX)immunodeficiency

Related Articles

    When Immunodeficiency & Autoimmunity Coexist

    January 17, 2019

    CHICAGO—Although rare, when a patient has both primary immune deficiency and autoimmune disease, the combination can lead to life-threatening complications requiring careful, long-term therapy. In When Immune Deficiency and Autoimmunity Coexist, a session at the 2018 ACR/ARHP Annual Meeting, M. Eric Gershwin, MD, the Jack and Donald Chia professor of Medicine and chief of Rheumatology,…

    Common Variable Immunodeficiency

    June 1, 2008

    Genetic insights into a complex and baffling disease

    A Mystery Case of Abdominal Masses

    May 13, 2021

    Common variable immuno­deficiency (CVID) is a common primary immuno­deficiency disease, with an estimated incidence of one per 25,000–50,000 individuals.1 The classic presen­tation includes frequent bacterial infections, secondary to dysfunctional B cell differ­entiation, impaired immunoglobulin production and diminished antibody response. The clinical presentation may be heterogenous and may include granulomatous disease as an uncommon manifestation. Granulo­matous…

    Basics of Biologic Joint Reconstruction

    April 6, 2012

    For young patients especially, this can delay knee replacement and provide better outcomes.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences